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1. Introduction 
The development of the mammary gland occurs in four distinct phases: embryogenesis, 
puberty, pregnancy, and a post-lactational phase involving profound levels of cell death and 
tissue remodeling. This post-lactational phase is termed post-lactational involution. During 
embryogenesis, a solid epithelial bud is generated in the embryonic ectoderm. As this bud 
continues to grow in cell number, the epithelial bud invaginates into the underlying 
mesenchyme forming the nascent mammary epithelium. The mammary epithelium grows 
as solid epithelial cords, lengthening distally and branching to form the rudimentary 
epithelial network. At puberty, ductal elongation continues in a proximal-to-distal direction, 
and side branches appear along the ducts. The side branches also lengthen distally, and 
continue to branch. This pattern of distal growth and branching fills the mouse mammary 
fat pad with an extensively branched epithelium by the end of puberty [6]. Similar to what is 
seen during embryonic mammary development and patterning, the mammary ducts 
developing during puberty originally appear in solid epithelial cords. Apoptosis canalizes 
the luminal space within the ducts, allowing a patent conduit for milk to traverse through 
the breast epithelium [1, 7]. Ultimately, the rodent mammary epithelium is comprised of a 
continuous, branching network leading from the nipple to primary ducts and smaller 
ductules that terminate in terminal end buds (TEBs), blunt ends or alveoli. The inner 
luminal cells are separated from the basement membrane by an outer myoepithelial layer. 
Myoepithelial cells secrete basement membrane components to which the epithelium 
attaches, and that physically separates the epithelium from the stromal compartment.  
Many morphological similarities exist between the mouse mammary gland and the human 
breast, although some distinctions exist. In the human breast, the cluster of epithelial acini 
arising from a single terminal duct, referred to as the terminal duct lobular unit (TDLU), is 
thought to be the milk-producing unit of the mammary gland. Therefore, the post-pubertal 
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human breast harbors cells capable of milk production even in the absence of pregnancy 
whereas the rodent mammary gland does not. However, profound expansion and 
differentiation of the TDLU population in the human breast is still required in order to 
render lactation successful.  
This expansion of the alveolar epithelium during pregnancy occurs in response to both local 
and systemic factors that drive mammary alveolar proliferation. In rodents, the entire 
secretory epithelium of the mammary gland develops during the gestation period of 
approximately three weeks, signifying a rapid 10-fold increase in epithelial content of the 
mammary gland. The mammary gland produces colostrum and then milk upon partuition. 
However, once offspring are weaned, the milk-producing lobuloalveolar cells are no longer 
necessary. Rather than being maintained, these secretory cells undergo programmed cell 
death in an exquisitely controlled and rapid process, while leaving the ductal epithelium 
intact. Dying cells are cleared from the post-lactational mammary gland rapidly and without 
causing acute inflammation, removing up to 90% of the total mammary epithelial content 
within the time span of just one week in rodent models.  This returns the mammary gland to 
an almost pre-pregnant state, so that the changes in the mammary gland that accompany 
pregnancy, lactation and involution may again occur with each successive pregnancy.  
The process of involution is complex requiring two distinct phases, the initiation of 
extensive cell death to remove the milk-producing epithelial cells, followed by the 
controlled influx of macrophages and other immune cell types to breakdown extracellular 
matrix, remodel blood vessels, replenish the adipocyte population in the mammary fatpad, 
and to phagocytically remove dead cells, residual milk, and debris.  This review will focus 
primarily on the events controlling cell death that occur within the first days of post-
lactational involution.  
2. Body 
2.1. Signaling mechanisms that control post-lactational apoptosis in the breast  
In recent years, molecular regulation of post-lactational involution has been studied 
primarily in the mouse mammary gland, due in large part to the relatively rapid gestation 
and nursing period in mice, and to the extensive use of genetically engineered mouse 
models.  These models, coupled with advances in transcriptional profiling have provided a 
detailed analysis of the dynamic cellular and molecular events occurring during the earliest 
days of involution, when the majority of programmed cell death occurs.  
2.2. Milk stasis 
Using teat-sealing to block milk delivery in a single mouse mammary gland, investigators 
demonstrated that a complex multi-step process initiating massive epithelial apoptosis is 
triggered by local stimuli produced in the sealed mammary gland, but not by changing 
levels of circulating hormones that are available to the remaining nine mouse mammary 
glands [8, 9]. These studies revealed that milk stasis is a primary trigger of post-lactational 
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cell death in the mammary gland [8]. Accumulation of milk within the secretory luminal 
space might initiate cell death by causing a mechanical stretch of these cells, or of cell-cell 
junctions [10]. It is clear that mechanical stress, including cell stretching, can initiate 
biological responses in several epithelial and endothelial cell types, and may activate 
signaling pathways known to trigger cell death in the post-lactational mammary gland. For 
example, cell stretching induces STAT3 phosphorylation, inhibition of the survival factor 
AKT, and expression of Leukemia Inhibitory Factor (LIF), each of which are critical during 
early post-lactational involution for the induction of cell death, as discussed below. Another 
potential explanation of milk stasis-induced cell death is that accumulation of milk 
components, such as calcium, may trigger cell death [11]. In support of this hypothesis, 
transcription of the plasma membrane protein calcium-ATPase 2 (PMCA2), which 
transports 60–70% of milk calcium [12], is dramatically and rapidly reduced during 
involution, perhaps due to self-limiting negative feedback in an effort to control potentially 
toxic divalent cation levels [13]. Loss of the gene encoding PMCA2 (Atp2b2) in mice caused 
precocious alveolar cell death at lactation. Interestingly, PMCA2 expression is also regulated 
by enforced shape changes in mammary epithelial cells [13]. Stanniocalcin-1 (STC-1), a 
newly discovered mammalian hormone that accumulates nearly 3-fold upon milk stasis 
[14], has recently been implicated as an inducer of post-lactational involution [15]. 
2.3. STAT3 
Transcriptional profiling studies of the mouse mammary gland at specific time points 
during lactation and post-lactational involution demonstrated that a specific subset of genes 
is dramatically induced within 12 hours of pup withdrawal, presumably in response to milk 
accumulation [4, 16]. It was hypothesized that this gene subset may represent potential 
‘master regulators’ of programmed cell death in the post-lactational mammary gland. This 
idea has been largely confirmed using genetically engineered mouse models that disrupt 
key expression events, resulting in a delay in post-lactational programmed cell death.  
The transcription factor Signal Transducer and Activator of Transcription (STAT) 3 was 
conditionally deleted in the mammary epithelium of genetically engineered mice, revealing 
its critical role in initiating the earliest events in post-lactational apoptosis [17-19]. While it 
has been known for some time that STAT3 regulates the expression of pro-inflammatory 
genes involved in the acute phase response (the early inflammatory response to tissue 
injury) [20, 21], and that many inflammation-related genes are expressed during post-
lactational involution [4, 22, 23], these studies were the first to demonstrate the molecular 
similarities that exist between the involuting mammary gland and the traditional wound 
healing scenario [23], despite the fact that involution-induced transcriptional responses are 
directed primarily by epithelial cells, while wound healing-induced transcriptional 
responses are directed by cells of the immune system.  
STAT3 is widely expressed, and is activated by tyrosine phosphorylation in response to 
numerous cytokines and growth factors [e.g. interleukin-6 (IL-6), IL-10, IL-17, IL-23, EGF] 
and tyrosine kinases (c-Src, Met, ErbB-2) [24]. Tyrosine phosphorylation of STAT3 allows 
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STAT3 dimers to translocate from the cytoplasm to the nucleus, where STAT3 binds to 
sequence-specific DNA elements in the promoters of STAT3 target genes. STAT3 activates 
gene transcription of many inflammation related genes, and can also repress the 
transcription of others. Although STAT3 transcriptional activity is associated with cell 
survival in several cell types including lymphomas and solid tumor epithelial cells [25-28], 
STAT3 takes on a different role in the post-lactational mammary gland, where STAT3 is 
required to initiate cell death. In the absence of STAT3, cell death was abrogated for at least 
6 days after pup withdrawal, despite milk stasis [18, 19]. Conversely, loss of suppressor of 
cytokine signaling (SOCS)-3, a negative regulator of STAT3, accelerated involution by 
increasing the rate of cell death following pup withdrawal [29, 30].  
A number of genes regulated by STAT3, such as CAAT/enhancer binding protein (C/ebp)δ, 
oncostatin M (OSM), OSM receptor (OSMR), and insulin-like growth factor (IGF) binding 
protein (IGFBP)-5, are also required in the post-lactational mammary epithelium to initiate 
cell death [31, 32]. OSM, a cytokine normally produced by macrophages but in this case 
produced by the mammary epithelium, is required during post-lactational involution, since 
OSMR knockout mice exhibited delayed involution [33].  Loss of C/ebpδ, a transcription 
factor involved in the acute phase response, also delayed mammary gland involution [31]. 
Because STAT3, and many target genes activated by STAT3, are critical triggers of cell death 
during post-lactational involution, it is likely that STAT3 lies at the apex of a transcriptionally-
activated signaling cascade that is required to initiate cell death in the post-lactational 
mammary epithelium. This role of STAT3 as an apoptosis inducer lies in contrast with 
observations that STAT3 is frequently activated in several cancer entities [28], correlating 
with heightened malignancy [34, 35]. Further, constitutive STAT3 activity promotes tumor 
formation in skin [36] and lung [37, 38]. The apparent discrepancy may be related to tissue 
specificity of STAT3 activity, or the activity of STAT3 in the tumor microenvironment (for 
example, in inflammatory cells) versus its role in the epithelial compartment of the tumor.  
2.4. NF-B 
Although the role of STAT3 in the induction of post-lactational apoptosis is clear, STAT3 
alone is insufficient to induce involution in the absence of nuclear factor-B (NF-B) 
signaling [39]. NF-κB comprises a family of five structurally and functionally related 
transcription factors [40]. Based on their transactivation properties, NF-B proteins are 
divided into two classes: Class I consists of RelA/p65, RelB, and c-Rel, while Class II includes 
NF-B1/p50 and NF-B2/p52. Each can dimerize in almost any combination but only class I 
proteins possess the C-terminal transactivation domains required for NF-B-mediated 
transcription of target genes. Under basal conditions, NF-B dimers are sequestered in the 
cytoplasm bound to the protein Inhibitor of B (IκB). Several signaling pathways can activate 
the IB kinases (IKKs) that phosphorylate IB, thus liberating NF-B dimers and allowing 
their nuclear translocation, where they bind to specific DNA sequences in target genes.  
Among this family of transcription factors, two NF-B subunits, RelA (p65) and p50 are 
expressed at different levels in the mammary epithelium throughout mammary gland 
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development. Furthermore, NF-B activity as measured in vivo using a transgenic NF-kB 
reporter model demonstrated two major peaks of NF-B-mediated trans-activation: one that 
occurs during pregnancy, and another that occurs during involution [41]. These data are 
consistent with reports showing that NF-B induced transcription of pro-survival genes [42-
45], and other reports showing that NFB activated transcription of pro-apoptotic genes [46-
48]. Therefore, it is possible that NF-B might drive cell growth and survival in the breast 
epithelium in some cases, but may regulate breast epithelial cell death in others. In support 
of the idea that NF-B might promote cell death, increased NF-B activity is rapidly induced 
after weaning, with strong increases seen within one hour of milk stasis in mouse mammary 
glands. NF-B activity remains elevated through the first four days of murine post-
lactational involution. Furthermore, loss of NF-B signaling in a genetically engineered 
mouse model of conditional IKK-β disruption decreased post-lactational NF-B signaling, 
resulting in decreased caspase-3 cleavage and delayed post-lactational apoptosis [39], 
confirming the importance of NFB signaling in post-lactational cell death of the secretory 
epithelium. Conversely, constitutively active IKK-β increased NF-B signaling, thus causing 
accelerated induction and higher rates of apoptosis during post-lactational involution [49]. 
Even in the absence of milk stasis, constitutively active IKK-β was capable of inducing 
apoptosis in the mouse secretory mammary epithelium, and therefore interfered with 
successful lactation by nursing dams.  
2.5. Akt/PI3K 
Intense interest in survival signaling pathways has revealed that phosphatidyl inositol 3-
kinase (PI3K) is a potent regulator of cell survival [50, 51]. Cancer cells frequently utilize 
PI3K signaling to promote cell survival under conditions of hypoxia, nutrient stress, or even 
to escape the cytotoxic effects of therapeutic anti-cancer treatments. It is clear, however, that 
non-transformed cells also use the PI3K signaling pathway to promote cell survival, and 
that increased PI3K signaling can interfere with physiological cell death [52]. PI3K is a 
heterodimer comprised of p110 (the catalytic domain) and p85 (the regulatory domain) [50, 
53]. Under basal conditions, p85 represses the catalytic activity of p110. However, SH2 
domains in p85 interact with phosphorylated tyrosines within YxxM motifs of receptor 
tyrosine kinases (RTKs) such as the insulin-like growth factor (IGF)-1 receptor (IGFR) or 
adaptor proteins, such as the insulin receptor substrate proteins.  This relieves p85-mediated 
inhibition of p110, allowing p110 to phosphorylate phosphatidyl inositol 2-phosphate 
(PIP2), thus generating PIP3, a powerful membrane-associated second messenger that 
recruits pleckstrin homology (PH)-domain containing proteins to the cell membrane. PDK1 
and Akt are two PH-domain containing proteins recruited to the membrane in response to 
RTK activation [52, 54, 55]. PDK1 is a serine-threonine kinase that phosphorylates Akt, 
another serine-threonine kinase that stimulates cell survival by interacting with members of 
the Bcl2 family of apoptosis regulators [56-58], which are also involved in the induction of 
cell death during involution [59-61]. For example, mammary-specific loss of the Bcl2 family 
member Bax, a known cell death inducer, decreased apoptosis during early involution [60, 
62-64], while overexpression of Bax within the secretory mammary epithelium increased 
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post-lactational apoptosis and promoted precocious STAT3 activity [7, 65]. Loss of the anti-
apoptotic protein Bcl-xL in the mammary gland during post-lactational involution 
accelerated cell death [66, 67]. By inactivating Bax and activating Bcl-xL, Akt activity 
increases cell survival in the secretory mammary epithelium. 
The role of PI3K/Akt signaling in suppressing post-lactational apoptosis is supported by 
genetically engineered mouse models that result in increased PI3K/Akt signaling. For 
example, a mouse model in which mammary-specific expression of myristoylated p110 
[68], a modified p110 that is restricted to the cell membrane, resulted in aberrantly elevated 
PI3K activity in the mammary epithelium and delayed post-lactational involution. Similarly, 
mammary-specific transgenic overexpression of Akt1 or Akt2 promoted cell survival and 
delayed post-lactational involution in mice [69, 70]. Conversely, ablation of Akt1, but not the 
ablation of Akt2 or Akt3, promoted apoptosis and accelerates involution [71], demonstrating 
isoform-specificity in the gene-dosage effects of Akt (overexpression versus ablation), and 
highlights the importance of Akt1 in the post-lactational mammary gland. Other studies 
demonstrated that Akt signaling is sustained during lactation by prolactin signaling [72-74]. 
This observation was confirmed in an independent transgenic mouse model of mammary-
specific STAT5 activation, in which STAT5 activity, when aberrantly sustained through 
post-lactational involution, upregulated Akt1 transcription and impaired apoptosis. These 
studies suggest that high levels of prolactin-induced STAT5 activity, as seen during 
lactation, maintains Akt1 expression and activity to promote cell survival, but when 
lactation ceases STAT5-induced Akt expression must be depleted in order for cells to 
undergo apoptosis [75]. 
Like prolactin signaling, other ligand-activated signaling cascades are capable of driving 
PI3K/Akt signaling during lactation, and if not turned off, can delay post-lactational 
apoptosis. For example, cell signaling initiated by IGF-1, which activates IGFR thus causing 
tyrosine phosphorylation of insulin receptor substrate proteins [76], potently activates the 
PI3K/Akt signal transduction cascade in the mammary epithelium during lactation. 
Overexpression of IGF-1 in the mouse mammary gland delayed post-lactational involution, 
suggesting that suppression of IGF-mediated cell survival is required for apoptosis to occur, 
and supporting the idea that PI3K signaling must be interrupted to initiate post-lactational 
apoptosis [77]. IGF-1 bio-availability is tightly controlled by IGF binding proteins (IGFBPs), 
which can sequester IGFs in the extracellular microenvironment of the mammary 
epithelium [78]. Consistent with the ability of IGF-1 to interfere with post-lactational cell 
death, one of the earliest transcriptional events during post-lactational involution is the 
upregulation of IGFBP-2 mRNA (4-fold), IGFBP-4 (6-fold) and IGFBP-5 mRNA (50-fold) 
[79]. This profound increase in IGFBP-5 is also seen at the protein level, and is conserved 
across several species. Increased expression of IGFBPs may limit IGF1-induced signaling, 
thus limiting IGF1-induced PI3K/Akt signaling [77, 80, 81]. Transgenic overexpression of 
IGFBP-5 in the mouse mammary gland increased caspase-3 cleavage (an indicator of 
apoptosis) and decreased the expression of the pro-survival factors Bcl-2 and Bcl-xL [80-84], 
suggesting that IGFBP-5 is pro-apoptotic. An IGF-1 analogue which binds weakly to IGFBP-
5 partially overcame IGFBP-5-induced cell death during post-lactational involution, 
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suggesting that IGFBP-5 was acting, at least in part, by inhibiting IGF action. Conversely, 
Igfbp5 null mammary glands exhibit delayed post-lactational apoptosis [78].  
2.6. TGFβ3 
While prolactin, IGF-1, and several RTK-activating ligands can activate PI3K/Akt signaling 
to promote cell survival, other ligands are capable of inducing cell death during post-
lactational involution, such as leukemia inhibitor factor (LIF) [85-87], serotonin [88], Fas 
ligand (FasL) [89] TRAIL [90], and transforming growth factor (TGF)-β3. Transcripts 
encoding TGF-β3, but not TGF-β1 or TGF-β2, substantially increase in the milk-producing 
cells during post-lactational involution [91, 92]. This rapid induction of TGF-β3 transcription 
in the secretory mammary epithelium occurs as early as 3 hours after pup withdrawal in 
response to milk stasis [93], and is among the most rapid gene expression changes occurring 
in response to post-lactational involution, suggesting that TGFβ3 might be an initiating 
signal for cell death during involution. It would be interesting to determine the impact of 
mechanical stress on expression from the TGFβ3 promoter. Consistent with the proposed 
role for elevated TGF-β3 in inducing apoptosis during involution, transgenic over-
expression of TGF-β3 in the secretory cells of the mouse mammary gland accelerated 
apoptosis during early post-lactational involution. Conversely, loss of TGFβ3 reduced post-
lactational apoptosis by nearly 70% [93], suggesting that autocrine TGF-β3 signaling initiates 
cell death following pup removal. 
The importance of the TGFβ3-induced signaling pathway for post-lactational apoptosis has 
been further investigated in genetically engineered mouse models. For example, loss of the 
TGFβ-regulated transcription factor Smad3 decreased post-lactational apoptosis by nearly 
40% [94]. Similarly, loss of TGF-β receptor type II  (TβRII) in the mammary epithelium, or 
transgenic expression of dominant negative (DN) TβRII decreased apoptosis during early 
post-lactational involution [95-97], consistent with a critical role for TGF-β3 signaling 
through TβRII and Smad3 to induce apoptosis during early involution. However, there is 
some discrepancy regarding the role of TGFβ signaling during involution, as transgenic 
expression of constitutively active TβRI decreased apoptotic cells in the mammary gland 
[98]. Perhaps elevated TβRI signaling activates signaling pathways not normally active 
under physiological conditions. 
2.7. Stromal-epithelial interactions 
The signaling pathways described above focus on those events occurring within the 
secretory epithelium that are responsible for initiating cell death during post-lactational 
involution. However, it is becoming more apparent that stromal cells contribute substantially 
to post-lactational apoptosis [99-103]. This was recently demonstrated in a transgenic mouse 
model referred to as MAFIA (macrophage Fas-induced apoptosis) [104]. Macrophages from 
MAFIA mice express a modified Fas receptor that, in response to a dimerization-inducing 
small molecule (AP20187), triggers Fas-mediated apoptosis. Depletion of macrophages 
immediately prior to weaning impaired apoptosis within the secretory mammary epithelium, 
despite milk stasis and STAT3 activation [105]. These results demonstrate that macrophages 
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are necessary to initiate apoptosis in the mammary epithelium. The underlying mechanism 
remains unclear at this point. However, it is possible that macrophages respond to signals 
emanating from mechanically stressed epithelia by producing factors that may activate the 
signaling pathways necessary for induction of apoptosis, or repress signaling pathways that 
may otherwise limit apoptosis. The transcriptional signatures generated from mouse 
mammary glands during involution were derived from whole tissue RNA, which would 
include not only epithelia but also the dynamic stromal components of the mammary gland. 
Therefore, it is possible that many expression events detected during early post-lactational 
involution are occurring within macrophage populations.  
Mast cells are also heavily recruited to the mammary gland during post-lactational 
involution [106], and like macrophages, are critical for epithelial apoptosis during mammary 
gland involution [107]. Specifically, mast cells produce plasma kallikrien (PKaI), the primary 
activator of plasminogen in the mammary gland. Expression of PKaI rapidly increases 
during involution, and while PKaI, plasminogen, and other serine proteases undoubtedly 
have a major role in tissue remodeling during later stages of involution, evidence suggests 
that PKaI also drives epithelial apoptosis. Inhibition of mast cell-derived PKaI during post-
lactational involution impaired epithelial cell death, suggesting that mast cells are vital for 
triggering apoptosis in the post-lactational mammary gland. Interestingly, in the absence of 
STAT3 within the mammary epithelium, mast cells and macrophages are not recruited to 
the mammary gland during post-lactational involution [108], suggesting that recruitment of 
stromal cells to the involuting mammary gland is initiated by early apoptotic signaling 
events occurring within the epithelial compartment (Fig. 1).  
2.8. Lysosomal membrane polarization  
Although most studies suggest that mammary gland involution occurs by apoptosis, it has 
been proposed recently that several morphological features of the involuting mammary 
gland may resemble necrosis rather than apoptosis [109]. These include cytoplasmic 
swelling, lack of membrane blebbing, and lack of nuclear fragmentation. Using mice 
deficient for both caspase 3 and 6, it was shown that mammary gland involution could 
proceed in the absence of these two classical activators of apoptosis, suggesting that perhaps 
alternative mechanisms of programmed cell death may exist in the post-lactational 
mammary gland. The authors proposed that STAT3 activity could upregulate expression of 
lysosomal cathepsins, which may leak from lysosomes to activate cell death pathways [110, 
111]. In support of this idea, cathepsin L is upregulated strongly with the onset of mammary 
involution [112]. Mice treated with a specific cathepsin L inhibitor during the first three days 
of involution demonstrated reduced cell death as compared to untreated mice [112]. 
Cathepsin-induced cell death can be simulated by ectopic addition of reactive oxygen 
species (ROS) to cultures of mammary epithelial cells.  Interestingly, the ROS nitric oxide 
(NO) can trigger mammary gland involution after weaning [113] in mice. While the role of 
apoptotic cell death in the mammary gland is widely accepted, investigators should be 
aware of alternative cell death pathways that contribute to programmed cell death during 
involution. 
 
Apoptosis and Clearance of the Secretory Mammary Epithelium 9 
 
Figure 1. Apoptosis in the post-lactational mammary epithelial cell (MEC) is initiated by three 
molecular signals that are each required: TGF3, NFB, and STAT3. Their loss impairs post-lactational 
apoptosis, despite continued milk stasis. Apoptotic MECs are cleared from the mammary gland by 
efferocytosis, or the phagocytic engulfment of dying cells. In the post-lactational mammary gland, 
MECs and macrophages engulf neighboring apoptotic cells. The phagocyte uses cell surface receptors to 
recognize, bind, and engulf apoptotic cells. These receptors include MerTK, Axl, v3 integrin and 
others. Intracellular signaling pathways that regulate cytoskeletal rearrangements (such as Rac 
signaling) are necessary for efferocytosis. Once engulfed into vesicles, apoptotic cells are degraded by 
the lysosomal pathway. Efferocytosis activates NF-B and STAT3, upregulating cytokines that are 
critical for post-lactational mammary remodeling. 
2.9. Pathologies of the breast due to aberrant regulation of apoptosis 
In the clinical setting, post-lactational involution of the secretory epithelium begins with 
milk stasis, at which point the secretory cells undergo apoptosis. Clearance of dying cells 
and residual milk is accomplished by phagocytes within the breast [114]. Regrowth of 
stromal adipose tissue and continued tissue remodeling returns the breast to a relatively 
quiescent state comprised of morphological structures similar to those found in nulliparous 
women. Rarely, the process of involution may be delayed. Failure to remove unnecessary 
lactational cells may result in symptomatic inflammatory tissue damage. Delayed involution 
in the human breast is characterized by the maintenance of secretory structures, loss of post-
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lactational apoptosis, and infiltration of the breast by inflammatory cells. Focal calcification 
may also be present [5]. Ductal distention of accumulated milk can be painful. Stagnant milk 
can be a source for infection and mastitis, to which the gland would respond with secretion 
of acute inflammatory cytokines and recruitment of leukocytes [115].  Similar to this clinical 
scenario, mouse models of delayed post-lactational cell death commonly develop mastitis 
[49, 108, 116].  
 
EMS 
receptor  
Bridging 
Molecule 
(BM) 
EMS Mammary Tissue and Cell Line 
Expression 
PSR - PS [117] Primary mouse mammary epithelia 
[117] 
TIMs - PS [118-124] unknown 
BAI1 - PS [125] unknown 
Stabilin-2 - PS [126, 127]. unknown 
ABCA1 unknown PS [128, 129] Bovine [130], mouse, human 
mammary [129] 
αvβ3 
integrin 
Vitronectin [131] 
Thrombospondin 
[132] 
MFG-E8 [133] 
PS [131, 132] Human MCF10A, MCF-7, and 
MDA-MB-231 cells [134] 
bovine [135], mouse mammary gland 
[136, 137] 
Tyro3 Gas6 [138] 
Protein S [139, 
140] 
PS [138] unknown 
Axl Gas6 [138, 141] PS [138, 141] Human breast [142] 
MerTK Gas6 [138] 
Protein S[140] 
PS [138, 140] Mouse mammary [116] 
CR3/CR4 unknown C3bi [143] unknown 
CD14 unknown ICAM [144] Bovine [145], canine [146], mouse [4], 
and human mammary [144, 147] 
CD68 unknown unknown Human, mouse mammary 
macrophages [148] 
CD163 unknown unknown Human breast [148] 
CD36 Thrombospondin 
[132] 
unknown MDA-MB-435, MDA-MB-231 human 
cells in mouse mammary [149] 
LRP β2GP1 [150] 
C1q [151] 
PS [150] 
Calreticulin 
[151] 
Rat mammary gland [152] 
Normal, transformed mammary 
epithelia [153] 
Marco 
[154] 
unknown unknown unknown 
Table 1. Key Factors Involved in Efferocytosis 
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Recent data garnered from mouse models of delayed post-lactational involution suggest that 
deregulation of post-lactational apoptosis may facilitate mammary tumor formation [34, 70, 
73, 155-157]. Observations made in human populations also suggest that altered post-
lactational involution may associate with tumor formation in the breast [100-102, 158].  This 
may reflect micro-environmental influences, or may be a function cell death-dependent 
removal of unnecessary breast epithelial cells in a regulated fashion. In many cancers, 
intrinsic cell deaths mechanisms become suppressed, contributing to the net growth of the 
transformed cell population. For example, activation of STAT5 in post-lactational mouse 
mammary glands delays apoptosis, and results in formation of mammary tumors that 
express estrogen and progesterone receptors (ER+PR+), as well as activated STAT3 and 
STAT5 [159]. Moreover, post-lactational transcriptional programs initiated by NF-κB and 
STAT3 not only support cell death, but also enhance tumor formation and progression by 
inducing expression of pro-tumorigenic cytokines [23, 24, 28, 34, 160-162]. Indeed, the 
transiently increased risk of developing breast cancer in the five years following a 
pregnancy may be greatly influenced by a deregulated tumor microenvironment developed 
in the post-lactational breast [101]. 
While post-lactational involution and age-related lobular involution are distinct processes, 
recent studies indicate that both are related to breast cancer development. Clinical studies 
show that completion of lobular involution may reduce future breast cancer incidence [163-
166]. With aging, there is a gradual loss of breast epithelial tissue that typically begins in 
peri-menopause, which then accelerates during menopause. Lobular involution is 
characterized by the apoptosis-mediated decrease in the size and complexity of the ductal 
tree and of the TDLU. This is distinct from post-lactational involution, which occurs very 
rapidly by comparison. However, similar mechanisms controlling apoptosis of the breast 
epithelium may occur in these two distinct models of involution.  
Lobular involution, like post-lactational involution, may inversely correlate with breast 
cancer risk, since premenopausal women who underwent partial or complete lobular 
involution had a substantially decreased incidence of breast cancer, while postmenopausal 
women who showed delayed lobular involution were found to have a correspondingly 
elevated breast cancer incidence [164]. While much remains to be learned about how lobular 
involution is regulated, some clinical studies and animal models suggest that IGF-1 may 
inhibit involution of lobules in the breast [163]. Clinically, a cross-sectional study among 472 
women demonstrated that higher IGF-1 levels associated with incomplete lobular 
involution, supporting the idea that IGF-1/PI3K/Akt-induced survival pathways prevent 
physiologic cell death, leading to pathological consequences.  
2.10. Introduction to efferocytosis in the breast 
Following apoptosis, one final event is needed to truly complete the life of the cell. This final 
step is phagocytic engulfment of apoptotic cells or ‘efferocytosis’. The term ‘efferocytosis’ 
was recently coined by Hensen et al. to distinguish phagocytic apoptotic cell removal from 
phagocytic pathogen removal [167]. While both processes are executed by phagocytes, they 
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result in distinctly different biological responses, one characterized by a dampened acute 
inflammatory response and upregulation of tolerogenic and wound healing effectors 
(efferocytosis), while the other is characterized by a pro-inflammatory response (pathogen 
removal). 
Efferocytosis is a carefully regulated process involving recruitment of phagocytes to the 
apoptotic cell, recognition of the apoptotic cell by the phagocytes, engulfment of the 
apoptotic cell by the phagocyte, and final breakdown of apoptotic cell components. If 
disrupted, apoptotic cells will undergo necrotic lysis, leading to acute inflammation, tissue 
damage and autoimmunity. Therefore, efferocytosis is critical for tissue homeostasis. 
However, recent discoveries indicate that the normal process of efferocytosis may be 
undesirable under certain pathological conditions, such as in the tumor microenvironment.  
We will discuss apoptotic cell clearance in the normal post-lactational breast and in the 
breast tumor microenvironment.  
2.11. The process of efferocytosis 
In general, clearance of apoptotic cells is often executed by macrophages and dendritic cells 
(DCs), but can also be performed by fibroblasts, endothelial and epithelial cells. A cell that 
engulfs an apoptotic cell through phagocytic mechanisms is called an efferocyte, regardless 
of its origin. Studies performed in cell culture and in vivo demonstrate that MECs and 
macrophages are both capable of engulfing apoptotic MECs during post-lactational 
involution of the secretory mammary epithelium [114, 116, 168]. 
Macrophages, the ‘professional phagocytes’ of the immune system, must infiltrate the 
mammary gland in response to the physiological presence of apoptotic cells during 
involution. Large quantities of bone marrow-derived and spleen-derived macrophages 
infiltrate the post-lactational mouse mammary gland in response to STAT3 activation and 
apoptosis of the mammary secretory epithelium. It is thought that apoptotic cells may 
release soluble chemo-attractants, or ‘find me’ signals, which recruit macrophages to the 
post-lactational mammary gland.  For example, Monocyte Chemo-attractant Protein-1 
(MCP-1/CCL2) is released from apoptotic cells in an NF-κB-dependent manner [169]. 
Interestingly, MCP-1 expression is strongly induced in the mammary gland at day 2 of 
involution, a time point that follows NF-B-induced cell death, and that precedes 
macrophage influx in the post-lactational mammary gland. These observations are 
consistent with NF-B-induced apoptosis followed by NF-B-induced expression of an 
efferocyte chemo-attractant, although this has not yet been demonstrated. Additional 
chemokines including CX3CL1, CCL6, CCL7, CCL8, and CXCL14, are induced during post-
lactational involution and may be signals that recruit macrophages to the involuting 
mammary gland to clear the accumulating apoptotic cell burden [170, 171] [4, 16]. 
Histological evidence of apoptotic cells within cytoplasmic vacuoles of mammary 
macrophages confirms that mammary macrophages engulf apoptotic cells during 
involution. Once present within the mammary gland, the macrophage identifies apoptotic 
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cells, scanning for signals that are present on the apoptotic cell but not a healthy cell, often 
referred to as an ‘eat me’ signal (EMS, Table 1).  The earliest and most recognized EMS is 
surface exposure of phosphatidylserine (PS). Healthy cells actively maintain PS on the inner 
plasma membrane leaflet. At the onset of apoptosis, PS is presented to the outer leaflet thus 
acting as a marker for a dying cell that requires engulfment [172-174]. EMSs are recognized 
by macrophages that express EMS receptors on their cell surface. EMS receptors may bind 
directly to the EMS on the dying cell. For example, the PS receptor (PSR), a transmembrane 
protein expressed by macrophages [128] and MECs [129], directly binds PS. Brain 
angiogenesis inhibitor 1 (BAI1) also binds PS directly, and is important for macrophage-
mediated efferocytosis [125], but has not yet been studied in the mammary gland. Stabilin-2 
and members of the T cell immunoglobin and mucin (TIM) family of receptors also directly 
bind PS [118-124, 126, 127], demonstrating mechanistic redundancy in the efferocytic 
pathways. It should be noted, however, that PS is an insufficient EMS, as macrophages fail 
to recognize live cells in which PS is forced to the outer leaflet [173, 175].  
While some EMS receptors bind apoptotic cell EMSs directly, other EMS receptors bind an 
extracellular bridging molecule that simultaneously binds the EMS and the EMS receptor 
(Table 1). For example, the bridging ligand milkfat globule epidermal growth factor-like 8 
(MFG-E8) binds to PS on apoptotic cells [133, 176, 177], while binding αvβ3 and αvβ5 
integrins expressed by macrophages. Growth arrest specific gene 6 (Gas6) and Protein S 
[178, 179] are bridging molecules that bind to the EMS receptors MerTK, Axl, and Tyro3 
[180] expressed by macrophages, while simultaneously binding PS on the apoptotic cell.  
Once the apoptotic cell is bound to the macrophage, intracellular signaling pathways must 
remodel the actin cytoskeleton to drive phagocytic ingestion of the apoptotic cell. Most of 
these events have been mapped out in Caenorhabditis elegans (C. elegans), which are discussed 
in detail within comprehensive reviews by Reddien et al. and Ravichandran et al. [181, 182].  
In mammalian macrophages, intracellular signaling networks that regulate actin 
cytoskeletal dynamics are required for apoptotic cell engulfment. For example, a protein 
complex comprised of CrkII, DOCK180, and ELMO causes activation of the Rac GTPase, a 
master regulator of actin cytoskeletal dynamics. Actin-dependent membrane extensions 
physically engulf the apoptotic cell [183-187].  Rac-mediated actin rearrangements are 
countered by RhoA [188], which prevents the formation of cell extensions needed for 
efferocytosis [189].  The engulfed apoptotic cell is then consumed by the efferocyte, 
primarily through lysosomal degradation.  Many signaling factors that drive apoptotic cell 
engulfment also enhance lysosomal degradation of apoptotic cells. For example, Rac is 
essential for maturation of phago-lysosomes in macrophages [190-193]. 
In addition to efferocytosis in the mammary gland, macrophages are also critical for 
cytokine modulation and extracellular matrix remodeling during the second phase of 
involution, underscoring the important role of macrophages in the post-lactational breast. 
Given their known role as professional phagocytes and their massive influx to the post-
lactational mammary gland, it is perhaps not surprising that efferocytosis by macrophages 
occurs in the post-lactational breast. What is more surprising is that apoptotic cell clearance 
occurs on a profound scale prior to the influx of macrophages to the involuting mammary 
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gland. Recent evidence demonstrated that MECs are the primary efferocytes of the breast 
during the earliest stages of post-lactational involution, the first three days prior to the 
influx of macrophages. The ability of MECs to act as efferocytes ensures a rapid response to 
the massive level of apoptosis that occurs during post-lactational involution. Loss of MEC-
mediated efferocytosis impairs post-lactational homeostasis, resulting in chronic mammary 
inflammation, scarring and inhibition of future lactation.   
Interestingly, MECs utilize many of the same EMS receptors used by macrophages to 
recognize apoptotic MECs. For example, MerTK is critical for MEC-mediated efferocytosis 
during post-lactational involution. MerTK loss from the mouse mammary epithelium causes 
apoptotic cell accumulation and milk stasis [116], despite the presence of wild-type 
macrophages. Interestingly, mRNA and protein expression of MerTK is dramatically 
upregulated by post-lactational day 1 within the luminal mammary epithelium. Similarly, 
the integrins αvβ3 and αvβ5 are expressed in the early post-lactational mammary epithelium. 
The αvβ5 bridging ligand, MFG-E8, is simultaneously induced [194], increasing the physical 
interaction between MFG-E8 and PS [136] and driving the clearance of membrane-coated 
milk components from the involuting mammary gland [195]. 
2.12. Physiological and pathological consequences of efferocytosis 
After the efferocyte removes the apoptotic cell, transcriptional events in the efferocyte result 
in cytokine, chemokine and growth factor production. The combined profile of the factors 
produced by the efferocyte promotes wound healing through enhanced tissue remodeling, 
angiogenesis, proliferation and resolution of acute inflammation. The efferocytosis-induced 
wound healing cytokine profile contrasts sharply to the cytokine profile produced in 
response to phagocytosis of pathogens, which is characterized by acute inflammatory 
cytokines [196]. In fact, efferocytosis is thought to be a key step in resolving or dampening 
acute inflammatory cytokine expression following tissue injury or pathogen exposure, 
resulting in repair and homeostasis [197].  Microarray analyses of mammary glands 
harvested at early post-lactational involution time points displayed a pronounced wound 
healing expression signature [3, 4, 158, 168, 198, 199], consistent with transcriptional changes 
that result from efferocytosis.  The prominent role of efferocytosis in re-establishing 
mammary homeostasis following widespread apoptosis of the secretory epithelium was 
shown by experiments in which loss of efferocytosis resulted in apoptotic cell accumulation, 
sustained milk stasis within ductal lumens, inflammation and scarring [116]. These 
pathological changes impaired lactation in future pregnancies.  
Although key to re-establishing homeostasis in the post-lactational mammary gland [116], 
recent evidence indicates that efferocytosis may support a more malignant tumor 
microenvironment [101, 102, 105, 106, 158, 198, 200-202]. Researchers are beginning to 
address the overlapping roles of efferocytic and metastasis-promoting cytokines. In 
agreement with this idea, mouse studies show that breast tumors grew more rapidly, 
invaded more readily, and formed distant metastases more efficiently when implanted in 
the post-lactational mammary gland as compared to implantation into a nulliparous 
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mammary gland [101].  One explanation for this observation is that post-lactational 
efferocytosis promotes breast tumor malignancy through production of wound healing 
cytokines, which are known to drive breast cancer growth and invasion. In support of this 
idea, MFG-E8 [203] and its receptor vβ3/5, as well as Gas6 and its ligand MerTK [116, 204] 
are frequently overexpressed in breast cancers. One recent study demonstrated that the pro-
tumorigenic cytokine IL-6 induces expression of MerTK, enhancing the ability of 
macrophages to engulf apoptotic cells and increasing production of wound healing 
cytokines such as IL-4 and IL-10 [205].  Recently published data implicates MerTK in breast 
cancer metastasis [206]. 
This observation has clinical relevance to pregnancy associated breast cancers (PABCs), 
defined as breast cancers that arise during the 5 years following a pregnancy. PABCs are 
among the most malignantly aggressive breast cancers, and are thus associated with poor 
prognosis. A better understanding of the processes outline above will undoubtedly expand 
the therapeutic options for these patients. 
3. Conclusion 
Altogether, these data support the hypothesis that targeting mediators of efferocytosis may 
limit pro-tumorigenic cytokine production. Moreover, it is becoming increasingly apparent 
that many factors within the mammary gland cooperate to ensure apoptosis and apoptotic 
cell clearance, highlighting the complexity of these processes and the need for more detailed 
investigations. Due to the dominant role of apoptosis and efferocytosis in maintaining tissue 
homeostasis, especially during post-lactational involution, the mammary gland provides an 
ideal platform for future study. 
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